<DOC>
	<DOCNO>NCT01299090</DOCNO>
	<brief_summary>Use RF device treat wrinkle neck</brief_summary>
	<brief_title>Prospective Pellevé™ Neck Wrinkle Study</brief_title>
	<detailed_description>This prospective study evaluate safety efficacy two treatment , space 30 day interval , use Surgitron® Dual RF™ S5 Pellevé™ wrinkle treatment handpiece Pellevé™ treatment gel treatment neck wrinkle .</detailed_description>
	<criteria>3070 year age Subjects clinical evidence neck wrinkle moderate severe severity specify grade 49 Fitzpatrick Wrinkle Assessment Scale . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study . Willingness ability provide write photo consent adherence photography procedure ( i.e. , removal jewelry makeup ) . Willingness ability provide write informed consent prior performance study related procedure . Subjects pregnant , nursing , plan become pregnant , and/or use reliable form birth control . Subjects prior exposure hyaluronic acid , filler , injection purpose 12 month precede study enrollment duration study . Subjects prior exposure botulinum toxin rhytids treatment area 6 month precede study enrollment duration study . Subjects prior cosmetic procedure improve rhytids treatment area ( i.e. , rhytidectomy , CO2/erbium laser resurfacing , Thermage/Thermacool radiofrequency treatment ) within 12 month visible scar may affect evaluation response and/or quality photography . Microdermabrasion , prescription level glycolic acid treatment within 3 month prior study participation study . Active cut , wound , infection skin . Oral Isotretinon within past 12 month . Active HSV1 . History keloid hypertrophic scar . Existing history skin malignancy treatment area past 12 month . Existing history skin disease treatment area past 12 month . History collagen vascular disease . Subjects implantable pacemaker , automatic implantable defibrillator/ cadioversor ( AICD ) , implantable electric device . Subjects use , within 30 day , medication cause dermal hypersensitivity affect skin characteristic . History autoimmune disease . History disease inhibits pain sensation . History Diabetes I II . Concurrent therapy , investigator 's opinion , would interfere evaluation safety efficacy study medication . Subjects anticipate need surgery overnight hospitalization study . Subjects , Investigator 's opinion , history poor cooperation , noncompliance medical treatment unreliability . Enrollment active study involve use investigational device drug .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>wrinkle</keyword>
	<keyword>rhytides</keyword>
</DOC>